John A. Lambert

John A. Lambert discloses dealings in Novavax Inc to SEC (Form 4). We count 11 filings; the first trade dates from 7 March 2007 and the latest from 2 July 2009.

On the open market, the record shows 1 purchase and 9 sales worth €70k. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant. Since January 2009: no purchases and 9 sales on the market.

Most recently, on 6 July 2009, the filings show an open-market sale worth €11k in Novavax Inc. The most recent open-market purchase was published on 4 August 2008, 6,671 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.